Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial

Eytan M. Stein, Amir T. Fathi, Courtney D. DiNardo, Daniel A. Pollyea, Gail J. Roboz, Robert H. Collins, Mikkael A. Sekeres, Richard M. Stone, Eyal C. Attar, Mark G. Frattini,

The Lancet Haematology · 2020 · 105 citations · 22 references

Concepts

References

22